APPLICATION
ANDA203002
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-18
LATEST ACTION
2023-05-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 8MEQ · CAPSULE, EXTENDED RELEASE · ORAL
POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 10MEQ · CAPSULE, EXTENDED RELEASE · ORAL
Approval history
2023-05-05Labeling · Supplement 4 · standardAP
2015-12-18UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.